Bevatas 300mg Solution for Infusion
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Bevacizumab (300mg)
Overview Bevatas 300mg Solution for Infusion
Infuseal 300mg intravenous solution is an anti-neoplastic agent indicated for various cancers including colorectal, non-small cell lung, renal, brain, ovarian, and cervical malignancies. Its mechanism of action involves angiogenesis inhibition, thereby restricting tumor growth. As a first-line treatment, Infuseal 300mg is highly effective when administered in combination with other chemotherapeutic agents via intravenous infusion (either directly into a vein or through a surgically implanted port). Dosage and treatment duration are determined by your oncologist, who will also monitor for infusion reactions such as hypertension and respiratory distress. Continued use depends on disease control and tolerability of side effects, a decision made solely by your physician. Regular monitoring of blood pressure and urinary protein levels may be advised. Common adverse effects include rectal hemorrhage, altered taste perception, and cephalalgia. Pre-surgical notification of Infuseal 300mg use is crucial due to its potential to impair wound healing and increase bleeding risk; any unusual bleeding should be immediately reported to your physician. Disclose pregnancy, pregnancy plans, or breastfeeding to your doctor. Complete transparency regarding all concurrent medications is essential, as drug interactions are possible.
Primary Ingredients of Bevatas 300mg Solution for Infusion
No text provided to rephrase.
Uses of Bevatas 300mg Solution for Infusion
Colorectal cancer, ovarian malignancy, cervical carcinoma, renal cell carcinoma, brain neoplasm, and non-small cell lung carcinoma.
Major Benefits of Bevatas 300mg Solution for Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Bevatas 300mg Solution for Infusion:
- Exfoliative dermatitis
- High blood pressure
- Nosebleeds
- Protein in urine
- Decreased appetite
- Electrolyte imbalance
- Peripheral sensory neuropathy
- Breathlessness
- Thromboembolism
- Wound healing complications
- Ovarian failure
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Mucosal inflammation
- Abscess
- Cellulitis
- Hypersensitivity
- Rectovaginal fistula
How to use Bevatas 300mg Solution for Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Bevatas 300mg Solution for Infusion works:
Bevatas 300mg intravenous solution is an anti-angiogenesis agent. Its mechanism of action involves inhibiting vascular endothelial growth factor (VEGF), thus preventing the development of blood vessels supplying tumors with oxygen and essential nutrients.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Bevatas 300mg Infusion Solution hasn't been established as safe. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Bevatas 300mg Infusion Solution during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. Your physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Infusion solution Bevatas 300mg is likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administering Bevatas 300mg Solution for Infusion may induce adverse reactions that could compromise driving aptitude. Drowsiness and loss of consciousness have been observed in patients receiving Bevatas 300mg Solution for Infusion, potentially affecting safe driving.
KidneySAFE IF PRESCRIBED
Infusional Bevatas 300mg is likely safe for individuals with impaired renal function. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Bevatas 300mg intravenous solution is likely safe for individuals with hepatic impairment. Current evidence indicates dose modification of Bevatas 300mg intravenous solution may be unnecessary in such cases. Physician consultation is recommended.
What if you forget to take Bevatas 300mg Solution for Infusion :
Omitting a scheduled dose of Bevatas 300mg intravenous solution requires contacting your physician.
Facts to Know About Bevatas 300mg Solution for Infusion
| Label | Value |
|---|---|
| Chemical Category | Monoclonal antibody |
| Developing Habits | No. |
| Type of Therapy | Cancer Treatments |
| Behavior Class | VEGF inhibitor |
3,018 People bought this recently